Metraipolis › archive › dc_875cd75831c8
Potential Utility of Combined Salivary Calprotectin and Anti-Cyclic Citrullinated Peptide in Rheumatoid Arthritis Assessment — Europe PMC PMID:41515518
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41515518
- DOI
- 10.3390/diagnostics16010023
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T12:03:59.894Z
- SHA-256 of the archived text
5b2d5ab5b92646617b761da0e0c1c04b0a7119c071d2760596191bae10e51fb9- Stable URL of this page
https://metraipolis.com/documento/dc_875cd75831c8
How to cite
Potential Utility of Combined Salivary Calprotectin and Anti-Cyclic Citrullinated Peptide in Rheumatoid Arthritis Assessment — Europe PMC PMID:41515518 — Europe PMC (en), https://europepmc.org/article/MED/41515518 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_875cd75831c8 (Metraipolis archive dc_875cd75831c8, sha256 5b2d5ab5b92646617b761da0e0c1c04b0a7119c071d2760596191bae10e51fb9)
BibTeX
@misc{dc875cd75831c8,
title = {Potential Utility of Combined Salivary Calprotectin and Anti-Cyclic Citrullinated Peptide in Rheumatoid Arthritis Assessment — Europe PMC PMID:41515518},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41515518},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_875cd75831c8; sha256 5b2d5ab5b92646617b761da0e0c1c04b0a7119c071d2760596191bae10e51fb9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41515518. Agents can read the archived copy with the MCP tool read_document.